H. Ansanay, M. Sebben, J. Bockaert, and A. Dumuis, Characterization of homologous 5- hydroxytryptamine4 receptor desensitization in colliculi neurons, Mol Pharmacol, vol.42, pp.808-816, 1992.

A. D. Bachstetter, C. M. Norris, P. Sompol, D. M. Wilcock, D. Goulding et al., Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology, Journal of Neuroscience, vol.32, issue.30, pp.10201-10210, 2012.
DOI : 10.1523/JNEUROSCI.1496-12.2012

K. Baranger, A. E. Bonnet, S. D. Girard, J. M. Paumier, L. Garcia-gonzalez et al., MT5-MMP Promotes Alzheimer???s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro, Frontiers in Molecular Neuroscience, vol.90, issue.163, 2016.
DOI : 10.1016/j.neuron.2016.05.003

K. Baranger, Y. Marchalant, A. E. Bonnet, N. Crouzin, A. Carrete et al., MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer???s disease, Cellular and Molecular Life Sciences, vol.8, issue.10, pp.217-236, 2016.
DOI : 10.1038/nn1531

K. Baranger, S. Rivera, F. D. Liechti, D. Grandgirard, J. Bigas et al., Endogenous and synthetic MMP inhibitors in CNS physiopathology, Prog Brain Res, vol.214, pp.313-351, 2014.
DOI : 10.1016/B978-0-444-63486-3.00014-1
URL : https://hal.archives-ouvertes.fr/hal-01718187

B. Haim, L. Carrillo-de-sauvage, M. A. Ceyzeriat, K. Escartin, and C. , Elusive roles for reactive astrocytes in neurodegenerative diseases, Front Cell Neurosci, vol.9, p.278, 2015.

J. Bockaert, S. Claeysen, V. Compan, and A. Dumuis, (4) receptors, a place in the sun: act two, Curr Opin Pharmacol, vol.11, pp.5-87, 2011.
DOI : 10.1016/j.coph.2011.01.012
URL : https://hal.archives-ouvertes.fr/hal-01667589

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, pp.239-259, 1991.
DOI : 10.1007/978-3-642-70644-8_2

M. Cachard-chastel, S. Devers, S. Sicsic, M. Langlois, F. Lezoualc-'h et al., Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice, Behavioural Brain Research, vol.187, issue.2, pp.455-461, 2008.
DOI : 10.1016/j.bbr.2007.10.008

F. A. Chaillan, E. Marchetti, B. Soumireu-mourat, and F. S. Roman, Selective impairment of subcategories of long-term memory in mice with hippocampal lesions accessed by the olfactory tubing maze, Behavioural Brain Research, vol.158, issue.2, pp.285-292, 2005.
DOI : 10.1016/j.bbr.2004.09.008
URL : https://hal.archives-ouvertes.fr/hal-00095168

G. Chene, A. Beiser, R. Au, S. R. Preis, P. A. Wolf et al., Gender and incidence of dementia in the Framingham Heart Study from mid-adult life, Alzheimer's & Dementia, vol.11, issue.3, pp.310-320, 2015.
DOI : 10.1016/j.jalz.2013.10.005
URL : https://hal.archives-ouvertes.fr/inserm-00936580

S. Cho and Y. Hu, Activation of 5-HT4 receptors inhibits secretion of ??-amyloid peptides and increases neuronal survival, Experimental Neurology, vol.203, issue.1, pp.274-278, 2007.
DOI : 10.1016/j.expneurol.2006.07.021

M. Cochet, R. Donneger, E. Cassier, F. Gaven, S. F. Lichtenthaler et al., Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10, ACS Chemical Neuroscience, vol.4, issue.1, pp.130-140
DOI : 10.1021/cn300095t
URL : http://europepmc.org/articles/pmc3547471?pdf=render

S. Consolo, S. Arnaboldi, S. Giorgi, G. Russi, and H. Ladinsky, 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex, NeuroReport, vol.5, issue.10, pp.1230-1232, 1994.
DOI : 10.1097/00001756-199406020-00018

N. Crouzin, K. Baranger, M. Cavalier, Y. Marchalant, C. Cohen-solal et al., Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer???s Disease: Dissociation between Somatosensory Cortex and Hippocampus, PLoS ONE, vol.27, issue.9, p.74667, 2013.
DOI : 10.1371/journal.pone.0074667.g003

D. Strooper and B. , Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process, Physiological Reviews, vol.5, issue.2, pp.465-494, 2010.
DOI : 10.1523/JNEUROSCI.1549-07.2007

A. T. Du, N. Schuff, D. Amend, M. P. Laakso, Y. Y. Hsu et al., Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.71, issue.4, pp.441-447, 2001.
DOI : 10.1136/jnnp.71.4.441

C. Dufouil, S. Seshadri, and G. Chene, Cardiovascular risk profile in women and dementia, J Alzheimers Dis, vol.42, pp.353-363, 2014.

R. Fol, J. Braudeau, S. Ludewig, T. Abel, S. W. Weyer et al., Viral gene transfer of APPs?? rescues synaptic failure in an Alzheimer???s disease mouse model, Acta Neuropathologica, vol.29, issue.2, pp.247-266, 2016.
DOI : 10.1523/JNEUROSCI.4104-09.2009

D. J. Fontana, S. E. Daniels, E. H. Wong, R. D. Clark, and R. M. Eglen, The Effects of Novel, Selective 5-Hydroxytryptamine (5-HT) 4 Receptor Ligands in Rat Spatial Navigation, Neuropharmacology, vol.36, issue.4-5, pp.689-696, 1997.
DOI : 10.1016/S0028-3908(97)00055-5

T. Freret, V. Bouet, A. Quiedeville, G. Nee, P. Dallemagne et al., Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT4 receptor activation (RS67333) on object recognition in mice, Behavioural Brain Research, vol.230, issue.1, pp.304-308, 2012.
DOI : 10.1016/j.bbr.2012.02.012
URL : https://hal.archives-ouvertes.fr/hal-00862757

G. Pourbadie, H. Naderi, N. Janahmadi, M. Mehranfard, N. Motamedi et al., Calcium channel blockade attenuates abnormal synaptic transmission in the dentate gyrus elicited by entorhinal amyloidopathy, Synapse, vol.25, issue.10, pp.408-417, 2016.
DOI : 10.1523/JNEUROSCI.4554-04.2005

P. Giannakopoulos, G. Gold, M. Duc, J. P. Michel, P. R. Hof et al., Neural substrates of spatial and temporal disorientation in Alzheimer's disease, Acta Neuropathologica, vol.100, issue.2, pp.189-195, 2000.
DOI : 10.1007/s004019900166

P. Giannoni, M. Arango-lievano, I. D. Neves, M. C. Rousset, K. Baranger et al., Cerebrovascular pathology during the progression of experimental Alzheimer's disease, Neurobiology of Disease, vol.88, pp.107-117, 2016.
DOI : 10.1016/j.nbd.2016.01.001

P. Giannoni, F. Gaven, D. De-bundel, K. Baranger, E. Marchetti-gauthier et al., Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer???s disease, Frontiers in Aging Neuroscience, vol.5, p.96, 2013.
DOI : 10.3389/fnagi.2013.00096
URL : https://hal.archives-ouvertes.fr/hal-01703910

S. D. Girard, G. Escoffier, M. Khrestchatisky, and F. S. Roman, The FVB/N mice: A well suited strain to study learning and memory processes using olfactory cues, Behavioural Brain Research, vol.296, pp.254-259, 2016.
DOI : 10.1016/j.bbr.2015.09.004
URL : https://hal.archives-ouvertes.fr/hal-01477821

S. D. Girard, M. Jacquet, K. Baranger, M. Migliorati, G. Escoffier et al., Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.29, issue.7, pp.762-772, 2014.
DOI : 10.1016/j.neurobiolaging.2006.12.004

M. E. Haahr, P. Fisher, K. Holst, K. Madsen, C. G. Jensen et al., receptor levels in hippocampus correlates inversely with memory test performance in humans, Human Brain Mapping, vol.73, issue.1-2, pp.3066-3074, 2013.
DOI : 10.1016/0166-4328(96)00108-8

M. Hartlage-rubsamen, A. Waniek, J. Meissner, M. Morawski, S. Schilling et al., Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer???s disease, Acta Neuropathologica, vol.8, issue.7, pp.565-583, 2015.
DOI : 10.1186/1742-2094-8-150

G. Hashimoto, M. Sakurai, A. F. Teich, F. Saeed, F. Aziz et al., 5-HT4 Receptor Stimulation Leads to Soluble A??PP?? Production Through MMP-9 Upregulation, Journal of Alzheimer's Disease, vol.32, issue.2, pp.437-445, 2012.
DOI : 10.3233/JAD-2012-111235

P. R. Heckman, C. Wouters, and J. Prickaerts, Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer???s Disease: A Translational Overview, Current Pharmaceutical Design, vol.21, issue.3, pp.317-331, 2015.
DOI : 10.2174/1381612820666140826114601

M. T. Heneka, M. J. Carson, J. Khoury, G. E. Landreth, F. Brosseron et al., Neuroinflammation in Alzheimer's disease, The Lancet Neurology, vol.14, issue.4, pp.388-405, 2015.
DOI : 10.1016/S1474-4422(15)70016-5

K. Herholz, S. Weisenbach, and E. Kalbe, Deficits of the cholinergic system in early AD, Neuropsychologia, vol.46, issue.6, pp.1642-1647, 2008.
DOI : 10.1016/j.neuropsychologia.2007.11.024

C. Hirata-fukae, H. F. Li, H. S. Hoe, A. J. Gray, S. S. Minami et al., Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, pp.92-103, 2008.
DOI : 10.1016/j.brainres.2008.03.079

J. R. Hodges and K. Patterson, Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications, Neuropsychologia, vol.33, issue.4, pp.441-459, 1995.
DOI : 10.1016/0028-3932(94)00127-B

D. E. Johnson, E. Drummond, S. Grimwood, A. Sawant-basak, E. Miller et al., The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal ?? Oscillations, Journal of Pharmacology and Experimental Therapeutics, vol.341, issue.3, pp.681-691, 2012.
DOI : 10.1124/jpet.112.192351

J. Jourquin, E. Tremblay, A. Bernard, G. Charton, F. A. Chaillan et al., Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory, 2005.
DOI : 10.1111/j.1460-9568.2005.04426.x
URL : https://hal.archives-ouvertes.fr/hal-00095130

U. A. Khan, L. Liu, F. A. Provenzano, D. E. Berman, C. P. Profaci et al., Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease, Nature Neuroscience, vol.1496, issue.2, pp.304-311, 2014.
DOI : 10.1016/j.neurobiolaging.2006.03.007
URL : http://europepmc.org/articles/pmc4044925?pdf=render

W. K. Kim, Y. Kan, D. Ganea, R. P. Hart, I. Gozes et al., Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-?? Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway, The Journal of Neuroscience, vol.20, issue.10, pp.3622-3630, 2000.
DOI : 10.1523/JNEUROSCI.20-10-03622.2000

M. Kitazawa, D. Cheng, M. R. Tsukamoto, M. A. Koike, P. D. Wes et al., Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal ??-Catenin Pathway Function in an Alzheimer's Disease Model, The Journal of Immunology, vol.187, issue.12, pp.6539-6549, 2011.
DOI : 10.4049/jimmunol.1100620
URL : http://www.jimmunol.org/content/jimmunol/187/12/6539.full.pdf

P. H. Kuhn, H. Wang, B. Dislich, A. Colombo, U. Zeitschel et al., ADAM10 is the physiologically relevant, constitutive ??-secretase of the amyloid precursor protein in primary neurons, The EMBO Journal, vol.16, issue.17, pp.3020-3032, 2010.
DOI : 10.1126/science.1132341

C. Lecoutey, D. Hedou, T. Freret, P. Giannoni, F. Gaven et al., Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, Proceedings of the National Academy of Sciences, vol.7, issue.5, pp.3825-3830, 2014.
DOI : 10.1016/0006-2952(61)90145-9

S. Letty, R. Child, A. Dumuis, A. Pantaloni, J. Bockaert et al., 5-HT 4 Receptors Improve Social Olfactory Memory in the Rat, Neuropharmacology, vol.36, issue.4-5, pp.681-687, 1997.
DOI : 10.1016/S0028-3908(96)00169-4

Y. Li, M. S. Tan, T. Jiang, and L. Tan, Microglia in Alzheimer???s Disease, BioMed Research International, vol.13, issue.3, p.437483, 2014.
DOI : 10.1016/j.brainresrev.2004.06.006

A. C. Lo, J. H. De-maeyer, B. Vermaercke, Z. Callaerts-vegh, J. A. Schuurkes et al., SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice, Neuropharmacology, vol.85, pp.178-189, 2014.
DOI : 10.1016/j.neuropharm.2014.05.013

K. Madsen, M. T. Haahr, L. Marner, S. H. Keller, W. F. Baare et al., C]SB207145 PET study, Journal of Cerebral Blood Flow & Metabolism, vol.32, issue.6, pp.1475-1481, 2011.
DOI : 10.1097/00004728-199207000-00024

K. Madsen, W. J. Neumann, K. Holst, L. Marner, M. T. Haahr et al., Cerebral Serotonin 4 Receptors and Amyloid-?? in Early Alzheimer's Disease, Journal of Alzheimer's Disease, vol.26, issue.3, pp.457-466, 2011.
DOI : 10.3233/JAD-2011-110056

M. Maillet, S. J. Robert, M. Cacquevel, M. Gastineau, D. Vivien et al., Crosstalk between Rap1 and Rac regulates secretion of sAPP??, Nature Cell Biology, vol.20, issue.7, pp.633-639, 2003.
DOI : 10.1016/0165-0270(87)90041-0

L. Manuel-apolinar, L. Rocha, D. Pascoe, E. Castillo, C. Castillo et al., Modifications of 5-HT4 receptor expression in rat brain during memory consolidation, Brain Research, vol.1042, issue.1, pp.73-81, 2005.
DOI : 10.1016/j.brainres.2005.02.020

E. Marchetti-gauthier, F. S. Roman, A. Dumuis, J. Bockaert, and B. Soumireu-mourat, BIMU1 Increases Associative Memory in Rats by Activating 5-HT 4 Receptors, Neuropharmacology, vol.36, issue.4-5, pp.697-706, 1997.
DOI : 10.1016/S0028-3908(97)00058-0

E. Marchetti, F. A. Chaillan, A. Dumuis, J. Bockaert, B. Soumireu-mourat et al., Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptors partial agonist, and an antagonist, Neuropharmacology, vol.47, issue.7, pp.1021-1035, 2004.
DOI : 10.1016/j.neuropharm.2004.06.033

E. Marchetti, A. Dumuis, J. Bockaert, B. Soumireu-mourat, and F. S. Roman, Differential modulation of the 5-HT4 receptor agonists and antagonist on rat learning and memory, Neuropharmacology, vol.39, issue.11, pp.2017-2027, 2000.
DOI : 10.1016/S0028-3908(00)00038-1

E. Marchetti, M. Jacquet, G. Escoffier, M. Miglioratti, A. Dumuis et al., Enhancement of reference memory in aged rats by specific activation of 5-HT4 receptors using an olfactory associative discrimination task, Brain Research, vol.1405, pp.49-56, 2011.
DOI : 10.1016/j.brainres.2011.06.020
URL : https://hal.archives-ouvertes.fr/hal-01770092

H. S. Nhan, K. Chiang, and E. H. Koo, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, Acta Neuropathologica, vol.5, issue.4, pp.1-19, 2015.
DOI : 10.4161/cam.5.4.16986
URL : http://europepmc.org/articles/pmc4282969?pdf=render

H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao et al., Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation, Journal of Neuroscience, vol.26, issue.40, pp.10129-10140, 2006.
DOI : 10.1523/JNEUROSCI.1202-06.2006
URL : http://www.jneurosci.org/content/jneuro/26/40/10129.full.pdf

K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss et al., ??-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease, Brain, vol.130, issue.11, pp.2837-2844, 2007.
DOI : 10.1093/brain/awm238
URL : https://academic.oup.com/brain/article-pdf/130/11/2837/948619/awm238.pdf

N. A. Py, A. E. Bonnet, A. Bernard, Y. Marchalant, E. Charrat et al., Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP, Front Aging Neurosci, vol.6, p.247, 2014.

L. Restivo, F. A. Chaillan, M. Ammassari-teule, F. S. Roman, and E. Marchetti, Strain Differences in Rewarded Discrimination Learning Using the Olfactory Tubing Maze, Behavior Genetics, vol.128, issue.1, pp.923-934, 2006.
DOI : 10.2466/pr0.1971.29.1.195

L. Restivo, F. Roman, A. Dumuis, J. Bockaert, E. Marchetti et al., The Promnesic Effect of G-protein-Coupled 5-HT4 Receptors Activation Is Mediated by a Potentiation of Learning-Induced Spine Growth in the Mouse Hippocampus, Neuropsychopharmacology, vol.77, issue.10, pp.2427-2434, 2008.
DOI : 10.1038/sj.npp.1301644

L. Restivo, F. S. Roman, M. Ammassari-teule, and E. Marchetti, Simultaneous olfactory discrimination elicits a strain-specific increase in dendritic spines in the hippocampus of inbred mice, Hippocampus, vol.523, issue.5, pp.472-479, 2006.
DOI : 10.1002/hipo.20174
URL : https://hal.archives-ouvertes.fr/hal-00095116

G. P. Reynolds, S. L. Mason, A. Meldrum, S. De-keczer, H. Parnes et al., 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases, British Journal of Pharmacology, vol.110, issue.Suppl 2, pp.993-998, 1995.
DOI : 10.1016/0028-3908(94)90084-1

C. Rochais, C. Lecoutey, F. Gaven, P. Giannoni, K. Hamidouche et al., R) Agonist Activities As Potential Agents against Alzheimer???s Disease: The Design of Donecopride, Journal of Medicinal Chemistry, vol.58, issue.7, pp.3172-3187, 2015.
DOI : 10.1021/acs.jmedchem.5b00115

K. M. Roddick, A. D. Roberts, H. M. Schellinck, and R. E. Brown, Sex and Genotype Differences in Odor Detection in the 3??Tg-AD and 5XFAD Mouse Models of Alzheimer???s Disease at 6 Months of Age, Chemical Senses, vol.37, issue.4, pp.433-440, 2016.
DOI : 10.1016/j.bbr.2012.09.019

F. S. Roman, E. Marchetti, A. Bouquerel, and B. Soumireu-mourat, The olfactory tubing maze: a new apparatus for studying learning and memory processes in mice, Journal of Neuroscience Methods, vol.117, issue.2, pp.173-181, 2002.
DOI : 10.1016/S0165-0270(02)00094-8
URL : https://hal.archives-ouvertes.fr/hal-00095340

C. C. Rowe and V. L. Villemagne, Brain Amyloid Imaging, Journal of Nuclear Medicine Technology, vol.41, issue.1, pp.11-18, 2013.
DOI : 10.2967/jnumed.110.076315

D. J. Selkoe, Soluble oligomers of the amyloid ??-protein impair synaptic plasticity and behavior, Behavioural Brain Research, vol.192, issue.1, pp.106-113, 2008.
DOI : 10.1016/j.bbr.2008.02.016
URL : http://europepmc.org/articles/pmc2601528?pdf=render

D. J. Selkoe and J. Hardy, The amyloid hypothesis of Alzheimer's disease at 25??years, EMBO Molecular Medicine, vol.8, issue.6, pp.595-608, 2016.
DOI : 10.15252/emmm.201606210

M. S. Silveira and R. Linden, Neuroprotection by cAMP, Adv Exp Med Biol, vol.557, pp.164-176, 2006.
DOI : 10.1007/0-387-30128-3_10

L. R. Squire and J. T. Wixted, The Cognitive Neuroscience of Human Memory Since H.M., Annual Review of Neuroscience, vol.34, issue.1, pp.259-288, 2011.
DOI : 10.1146/annurev-neuro-061010-113720
URL : http://europepmc.org/articles/pmc3192650?pdf=render

U. Staubli, D. Fraser, M. Kessler, and G. Lynch, Studies on retrograde and anterograde amnesia of olfactory memory after denervation of the hippocampus by entorhinal cortex lesions, Behavioral and Neural Biology, vol.46, issue.3, pp.432-444, 1986.
DOI : 10.1016/S0163-1047(86)90464-4

J. Tack, E. Quigley, M. Camilleri, L. Vandeplassche, and R. Kerstens, Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis, United European Gastroenterology Journal, vol.9, issue.1, pp.48-59, 2013.
DOI : 10.3748/wjg.v13.i5.732

A. V. Terry, . Jr, J. J. Buccafusco, W. J. Jackson, M. A. Prendergast et al., Enhanced delayed matching performance in younger and older macaques administered the 5-HT 4 receptor agonist, RS 17017, Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017, pp.407-415, 1998.
DOI : 10.1007/s002130050529

I. Tesseur, A. A. Pimenova, A. C. Lo, M. Ciesielska, S. F. Lichtenthaler et al., Chronic 5-HT4 receptor activation decreases A?? production and deposition in hAPP/PS1 mice, Neurobiology of Aging, vol.34, issue.7, pp.1779-1789, 2013.
DOI : 10.1016/j.neurobiolaging.2013.01.020

A. Thathiah and B. De-strooper, The role of G protein-coupled receptors in the pathology of Alzheimer's disease, Nature Reviews Neuroscience, vol.156, issue.2, pp.73-87, 2011.
DOI : 10.1016/j.neuroscience.2008.07.042

K. Varnas, C. Halldin, V. W. Pike, and H. Hall, Distribution of 5-HT4 receptors in the postmortem human brain???an autoradiographic study using [125I]SB 207710, European Neuropsychopharmacology, vol.13, issue.4, pp.228-234, 2003.
DOI : 10.1016/S0924-977X(03)00009-9

L. Velayudhan, P. Proitsi, E. Westman, J. S. Muehlboeck, P. Mecocci et al., Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease, J Alzheimers Dis, vol.33, pp.755-766

J. Vina and A. Lloret, Why Women Have More Alzheimer's Disease Than Men: Gender and Mitochondrial Toxicity of Amyloid-?? Peptide, Journal of Alzheimer's Disease, vol.20, issue.s2, pp.527-533, 2010.
DOI : 10.3233/JAD-2010-100501

D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl et al., Naturally secreted oligomers of amyloid ?? protein potently inhibit hippocampal long-term potentiation in vivo, Nature, vol.36, issue.6880, pp.535-539, 2002.
DOI : 10.1021/jm00054a014

M. Willem, S. Tahirovic, M. A. Busche, S. V. Ovsepian, M. Chafai et al., ??-Secretase processing of APP inhibits neuronal activity in the hippocampus, Secretase processing of APP inhibits neuronal activity in the hippocampus, pp.443-447
DOI : 10.1073/pnas.1232232100

T. Wyss-coray, J. D. Loike, T. C. Brionne, E. Lu, R. Anankov et al., Adult mouse astrocytes degrade amyloid-?? in vitro and in situ, Nature Medicine, vol.20, issue.4, pp.453-457, 2003.
DOI : 10.1038/87945

T. Wyss-coray and J. Rogers, Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature, Cold Spring Harbor Perspectives in Medicine, vol.2, issue.1, 2012.
DOI : 10.1101/cshperspect.a006346

Z. Zhang, M. Song, X. Liu, S. Kang, S. Duong et al., Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer???s disease, Nature Communications, vol.13, issue.1, 2015.
DOI : 10.1038/npp.2013.243
URL : http://www.nature.com/articles/ncomms9762.pdf